TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 101 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,874,000 | +39.5% | 40,000 | 0.0% | 0.04% | +15.2% |
| Q3 2020 | $3,494,000 | +35.2% | 40,000 | 0.0% | 0.03% | +22.2% |
| Q2 2020 | $2,584,000 | +44.7% | 40,000 | 0.0% | 0.03% | +17.4% |
| Q1 2020 | $1,786,000 | -52.2% | 40,000 | -33.3% | 0.02% | -30.3% |
| Q4 2019 | $3,737,000 | +65.6% | 60,000 | 0.0% | 0.03% | +43.5% |
| Q3 2019 | $2,256,000 | -7.6% | 60,000 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $2,442,000 | – | 60,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |